Abstract:Background Gastric cancer (GC) is a leading global health problem. In most areas of the world, the incidence rate of GC in males was 1.5- to 3- fold higher than that in females. The androgen receptor (AR) is an independent adverse prognostic factor in patients with GC. However, the mechanism of AR regulating the progression of GC remains unclear. The aim of this study is to determine the effect of AR on the progression of GC and the mechanism behind these effects, which will provide novel ideas for the treatment of GC. Methods The relative expression of AR were detected by semi-quantitative RT-PCR and real-time quantitative PCR. The functions of AR in GC were determined by colony formation experiment, transwell migration and invasion assay. The clinical data were obtained from the website cBioPortal and XENA database. The potential mechanism of AR in GC was searched by Gene Set Enrichment Analysis (GSEA) and DAVID. Chromatin immunoprecipitation (ChIP) and PCR were performed to explore the function of AR as a transcriptional factor. The xenograft mouse models in nude mice were used to verify the function of CCRK in vivo. Results The expression of AR was upregulated in 6/8 GC cell lines. Compared to adjacent tissues, it’s expression of GC was higher. Ectopic expression of AR promoted the colony-formation ability, migration and invasion of GC cells. In contrast, the knockdown of AR showed the opposite effects. Remarkably, we found that AR regulated the expression of cell cycle related kinase (CCRK) through transcriptional regulation. The AR-CCRK axis promoted GC development through phosphorylation of GSK3β and β-catenin. Furthermore, TCGA data revealed that high expression of AR or CCRK was related with poor prognosis of GC patients. The prognosis of patients with concurrent high expression of AR and CCRK was significantly worse than that of patients with low expression of both AR and CCRK. Conclusions The expression of CCRK is increased by AR in GC. Low expression levels of AR and CCRK are related to better prognosis in GC patients, suggesting they are also candidates as prognostic indicators in GC.

Androgen Receptor (AR) Promotes Male Bladder Cancer Cell Proliferation and Migration Via Regulating CD24 and VEGF.

Androgen Receptor is a Potential Therapeutic Target for Bladder Cancer

The androgen receptor in bladder cancer

Activated Androgen Receptor Promotes Bladder Cancer Metastasis Via Slug Mediated Epithelial-Mesenchymal Transition

Expression and Clinical Significance of Androgen Receptor in Bladder Cancer: A Meta-Analysis.

Androgen Receptor Regulates CD44 Expression in Bladder Cancer

The Molecular Mechanisms of Androgen Receptor in Nephrolithiasis.

The androgen and androgen receptor in the progression of bladder cancer research

Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer

Androgen Receptor Suppresses Prostate Cancer Metastasis but Promotes Bladder Cancer Metastasis Via Differentially Altering Mirna525-5P/slpi-mediated Vasculogenic Mimicry Formation

EDARADD Silencing Suppresses the Proliferation and Migration of Bladder Cancer Cells

Androgen receptor transcriptionally inhibits programmed death ligand-1 (PD-L1) expression and influences immune escape in bladder cancer

The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells

Data from Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals

Inactivation of AR/TMPRSS2-ERG/Wnt Signaling Networks Attenuates the Aggressive Behavior of Prostate Cancer Cells

Infiltrating Neutrophils Increase Bladder Cancer Cell Invasion Via Modulation of Androgen Receptor (AR)/MMP13 Signals

Roles of Androgen Receptor Signaling in Urothelial Carcinoma

Androgen Dihydrotestosterone (DHT) Promotes the Bladder Cancer Nuclear AR-negative Cell Invasion Via a Newly Identified Membrane Androgen Receptor (Mar-Slc39a9)-mediated Gαi Protein/mapk/mmp9 Intracellular Signaling

IDDF2019-ABS-0263 Androgen Receptor Promotes Gastric Carcinogenesis Via Upregulating the Expression of Cell Cycle-Related Kinase

Influence of estrogen receptor a on proliferation and metastasis in bladder cancer cells

Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner